Ahmedabad

Tweet India Pharmaceuticals Pvt. Ltd. is being headed by Mr. A. K. Arora, who is backed up by his more than 35 years practical and successful experiences of Pharmaceutical Industry and has given his precious and valuable guidance in formulating latest strategies which is followed by many Pharmaceutical Companies, and has been the milestone for the Pharmaceutical Industries.
Mr. Arora has created history in establishing many products which are essential and are in the interest of the mankind. His last assignment for the last 22 years as one of the partner with Talent India has given the new heights, and created history in the industry.

Candidates after submitting their applications through On-Line shall send photocopies of their all academic/required documents regarding their claims along with print out of On-Line application form within 21 days from the last date of submitting the applications (date 03rd October, 2016 till 5.00 O' Clock) on the working day through registered/Speed Post or Personally in the office of the Commission.

Torrent Pharmaceuticals Limited, is a dominant player in the therapeutic areas of cardiovascular (CV) and central nervous system (CNS) and has achieved significant presence in gastro-intestinal, diabetology, anti-infective and pain management segments. Torrent Pharma’s competitive advantage as a manufacturer stems from its world-class manufacturing facilities. Its manufacturing facilities at Indrad, Gujarat, comply with WHO, cGMP, MHRA and TGA norms and have received ISO 9001, ISO 14001 and OHSAS 18001

Post: QA, QC, TABLET, PACKAGING

National Health Mission (NHM) encompassing two Sub-Missions, National Health Mission (NHM) and National Urban Health Mission (NUHM). It is both flexible and dynamic and is intended to guide States towards ensuring the achievement of universal access to health care through strengthening of health systems, institutions and capabilities.

Post : Pharmacist Cum Data Assistant (AYUSH Pharmasy)

Zydus Hospira Oncology Private Limited (ZHOPL) is a 50%-50% joint venture (JV) company between Zydus Cadila. India and Hospira (a Pfizer company), manufacturing cytotoxic injectable products (Finished Products). With our past success in more than 30 regulatory inspections including USFDA. MHRA, PMDA. Japan etc... we now embark upon a journey of Self Reliant and making ZHOPL, a Centre of Excellence (CoE) for Oncology products.

(1).Crystalluria is the side effect associated with:
1. Quinolones 
2. Azoles
3. Sulphonamides
4. Taxol

In 2014, a Core Committee was constituted under the Chairmanship of Dr. VM Katoch by the Indian Health Ministry to revise National List of Essential Medicines (NLEM), 2011. In the process of revision of NLEM, several consultations were held across the country with experts from different domains.

Leading Pharma Company- Nextus

Post: Area Manager